Skip to Content

WATSON 837 15 (Clorazepate Dipotassium 15 mg)

Pill with imprint WATSON 837 15 is Pink, U-shape and has been identified as Clorazepate Dipotassium 15 mg. It is supplied by Watson Pharmaceuticals.

Clorazepate is used in the treatment of anxiety; alcohol withdrawal; seizure prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 15 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 837 15

Clorazepate Dipotassium

Imprint
WATSON 837 15
Strength
15 mg
Color
Pink
Shape
U-shape
Availability
Prescription only
Drug Class
Benzodiazepines
Pregnancy Category
N - Not classified
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
52544-0837

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.